Title:
SILSESQUIOXANE DERIVATIVE, CURABLE COMPOSITION, CURED PRODUCT, AND BASE MATERIAL
Document Type and Number:
WIPO Patent Application WO/2023/100992
Kind Code:
A1
Abstract:
A silsesquioxane derivative represented by formula (1). In formula (1), R1 is a hydrogen atom or a C1-6 alkyl group, R2 is a C1-10 alkylene group, a C3-10 cycloalkylene group, a C6-10 arylene group, or a C7-12 aralkylene group, R3 is a fluoro group or a C1-20 fluoroalkyl group, R6 is a C2-12 organic group having at least one of an ethylenically unsaturated bond and a carbon-carbon triple bond, R7 is a C1-10 alkyl group, a C6-10 aryl group, or a C7-10 aralkyl group, and u, v, and y are positive numbers.
Inventors:
IWASE YOSHIAKI (JP)
ARAKAWA MASAYUKI (JP)
OZEKI NARUMI (JP)
FURUTA NAOMASA (JP)
ARAKAWA MASAYUKI (JP)
OZEKI NARUMI (JP)
FURUTA NAOMASA (JP)
Application Number:
PCT/JP2022/044463
Publication Date:
June 08, 2023
Filing Date:
December 01, 2022
Export Citation:
Assignee:
TOAGOSEI CO LTD (JP)
International Classes:
C08F30/08; C08F290/06; C08G77/24
Domestic Patent References:
| WO2008123122A1 | 2008-10-16 |
Foreign References:
| JP2017529452A | 2017-10-05 | |||
| JP2019501148A | 2019-01-17 | |||
| JP2019070071A | 2019-05-09 | |||
| JP2019094381A | 2019-06-20 | |||
| JP2017508013A | 2017-03-23 | |||
| KR20100131312A | 2010-12-15 | |||
| CN104610549A | 2015-05-13 |
Attorney, Agent or Firm:
TAIYO, NAKAJIMA & KATO (JP)
Download PDF: